Domov › Rakovina pľúc › Texas › San Antonio
Klinické štúdie Rakovina pľúc v meste San Antonio, TX
26 štúdií pre Rakovina pľúc hľadá účastníkov v zariadeniach v meste San Antonio a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study of ZW251 in Participants With Advanced Solid Tumors
Prebieha náborFáza 1
- START San Antonio, San Antonio
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Prebieha náborFáza 1/2
- New Experimental Therapeutics of San Antonio - NEXT Oncology, San Antonio
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Audie L Murphy VA Hospital, San Antonio
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Prebieha náborFáza 1
- University of Texas San Antonio (UTSA), San Antonio
A Study of PHN-012 in Patients With Advanced Solid Tumors
Prebieha náborFáza 1
- PHN-012-001 Site, San Antonio
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Prebieha náborFáza 2/3
- Local Institution - 0173, San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Prebieha náborFáza 1/2
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Prebieha náborFáza 1
- NEXT, San Antonio
- START - San Antonio, San Antonio
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Prebieha náborFáza 1/2
- START San Antonio, San Antonio
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Prebieha náborFáza 1
- START - San Antonio, San Antonio
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Prebieha náborFáza 1/2
- Avenzo Therapeutics Recruiting Site, San Antonio
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Prebieha náborFáza 1
- START San Antonio, San Antonio
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- UT Health Mays Cancer Center, San Antonio
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Prebieha náborFáza 1
- START - San Antonio, San Antonio
IDOV-Immune for Advanced Solid Tumors
Prebieha náborFáza 1
- South Texas Accelerated Research Therapeutics, San Antonio
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
Prebieha nábor
- Audie Murphy VA Medical Center, San Antonio
- Brooke Army Medical Center, San Antonio
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Prebieha náborFáza 1/2
- Mays Cancer Center / University of Texas, San Antonio, San Antonio
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Prebieha náborFáza 1
- NEXT Oncology, San Antonio
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Prebieha náborFáza 1
- Research Site #2, San Antonio
- Research Site, San Antonio
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Prebieha náborFáza 1
- START, San Antonio
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Prebieha náborFáza 1/2
- NEXT Oncology, San Antonio
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Prebieha náborFáza 1/2
- Next Oncology, San Antonio
Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
Prebieha náborObservačná štúdia
- UT Health San Antonio, M.D. Anderson Cancer Center, San Antonio
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Prebieha náborFáza 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
- UT Health San Antonio, San Antonio
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
Prebieha náborFáza 1/2
- Next Oncology, San Antonio, San Antonio
Collection of Sputum and Labeling for Lung Cancer
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- South Texas Veterans Health Care System (STVHCS)/Audie L. Murphy Memorial Veterans Hospital, San Antonio
Štúdie Rakovina pľúc v iných mestách
- Houston, TX78 štúdií
- Boston, MA62 štúdií
- New York City, NY60 štúdií
- Los Angeles, CA45 štúdií
- Arlington, VA41 štúdií
- Washington, DC41 štúdií
- Chicago, IL41 štúdií
- Baltimore, MD40 štúdií
- Nashville, TN40 štúdií
- St. Louis, MO39 štúdií
- Columbus, OH37 štúdií
- Philadelphia, PA36 štúdií
Iné štúdie v San Antonio
- Nemalobunkový karcinóm pľúc59 štúdií
- Rakovina prsníka47 štúdií
- Kolorektálny karcinóm46 štúdií
- Metastatická rakovina44 štúdií
- Rakovina (všetky typy)41 štúdií
- Obézita40 štúdií
- Diabetes mellitus 2. typu37 štúdií
- Nadváha34 štúdií
- Rakovina vaječníkov31 štúdií
- Rakovina pankreasu31 štúdií
- Rakovina prostaty28 štúdií
- Rakovina endometria27 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.